PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 3 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Berberine (found in yellowroot) has demonstrated lipid-lowering and insulin-resistance improving actions in numerous randomized clinical trials [PMID:27671811].
Preliminary clinical evidence suggests berberine can reduce endothelial inflammation to improve vascular health, including in patients with cardiovascular disease [PMID:27671811].
Evidence summary
PubMed sources
- 1.PMID: 27671811 (2016) — Berberine and Its Role in Chronic Disease. · Advances in experimental medicine and biology
- 2.PMID: 40857125 (2025) — A mini review on marshal (yellowroot): phytochemistry and ethnobotanical significance. · Natural product research